Technical advance

Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization

Last 30 days: 106 accesses
Last 365 days: 1995 accesses
All time: 2665 accesses

Jens Mollerup^*, Ulla Henriksen, Sven Müller and Andreas Schønau

BMC Clinical Pathology 2012, 12:3 doi:10.1186/1472-6890-12-3

Accesses